* Your assessment is very important for improving the workof artificial intelligence, which forms the content of this project
Download Leukaemia Section t(8;12)(q24;q22) Atlas of Genetics and Cytogenetics in Oncology and Haematology
Survey
Document related concepts
Epigenetics in stem-cell differentiation wikipedia , lookup
Point mutation wikipedia , lookup
Site-specific recombinase technology wikipedia , lookup
Artificial gene synthesis wikipedia , lookup
Genome (book) wikipedia , lookup
Designer baby wikipedia , lookup
Gene therapy of the human retina wikipedia , lookup
Therapeutic gene modulation wikipedia , lookup
Epigenetics of human development wikipedia , lookup
X-inactivation wikipedia , lookup
Vectors in gene therapy wikipedia , lookup
Mir-92 microRNA precursor family wikipedia , lookup
Transcript
Atlas of Genetics and Cytogenetics in Oncology and Haematology OPEN ACCESS JOURNAL AT INIST-CNRS Leukaemia Section Short Communication t(8;12)(q24;q22) Jean-Loup Huret Genetics, Dept Medical Information, University of Poitiers, CHU Poitiers Hospital, F-86021 Poitiers, France Published in Atlas Database: October 2007 Online updated version: http://AtlasGeneticsOncology.org/Anomalies/t0812q24q22ID2057.html DOI: 10.4267/2042/38605 This work is licensed under a Creative Commons Attribution-Non-commercial-No Derivative Works 2.0 France Licence. © 2008 Atlas of Genetics and Cytogenetics in Oncology and Haematology Protein B-cell translocation gene 1 (BTG1) is an antiproliferative gene; it regulates cell growth and differentiation. BTG1 is strongly expressed in the G0/G1 phases of the cell cycle, and then downregulated during the G1 phase. Overexpression of BTG1 results in a retardation of cell proliferation. Potentially high-affinity self-reactive B cells are eliminated through the interaction of membrane Ig (mIg) with self-antigens. Anti-IgM upregulates BTG1 and BTG2, resulting in growth inhibition. Engagement of mIg on the cells results in G1 arrest and eventual apoptosis. Clinics and pathology Disease Chronic lymphocytic leukemia (CLL) in blastic transformation. Note: CLL was diagnosed after bone marrow recovery following intensive chemotherapy for acute lymphoblastic leukemia. Epidemiology Only one case to date, 69-year-old female patient. Cytogenetic The patient had a primary t(11;14)(q13;q32) in all lymphocytic/lymphoblastic cells. A subpopulation of cells carried in addition a t(8;12)(q24;q22) together with the loss of the normal chromosome 8 and homozygosity for the abnormal der(8). It is likely that the t(11;14) corresponded to the CLL, and the subclone with t(8;12) to the blast population. References Archimbaud E, Charrin C, Gentilhomme O, Rimokh R, Guyotat D, Fiere D, Germain D. Initial clonal acute lymphoblastic transformation of chronic lymphocytic leukemia with (11;14) and (8;12) chromosome translocations and acquired homozygosity. Acta Haematol 1988;79(3):168-73. Rimokh R, Rouault JP, Wahbi K, Gadoux M, Lafage M, Archimbaud E, Charrin C, Gentilhomme O, Germain D, Samarut J, et al. A chromosome 12 coding region is juxtaposed to the MYC protooncogene locus in a t(8;12)(q24;q22) translocation in a case of B-cell chronic lymphocytic leukemia. Genes Chromosomes Cancer 1991 Jan;3(1):24-36. Prognosis The patient died 5 months after initial blastic phase. Genes involved and Proteins MYC Iwai K, Hirata K, Ishida T, Takeuchi S, Hirase T, Rikitake Y, Kojima Y, Inoue N, Kawashima S, Yokoyama M. An antiproliferative gene BTG1 regulates angiogenesis in vitro. Biochem Biophys Res Commun 2004 Apr 9;316(3):628-35. Location: 8q24 Protein Transcription factor binding to specific DNA sequences, upon dimerization to Max (Max can also form heterodimers with Mad as well as homodimers with itself). Myc/Max complexes activate transcription and promote cell proliferation and transformation. Mad/Max complexes, repress transcription. Hata K, Nishijima K, Mizuguchi J. Role for Btg1 and Btg2 in growth arrest of WEHI-231 cells through arginine methylation following membrane immunoglobulin engagement. Exp Cell Res 2007 Jul 1;313(11):2356-66. This article should be referenced as such: Huret JL. t(8;12)(q24;q22). Atlas Genet Cytogenet Oncol Haematol.2008;12(6):455. BTG1 Location: 12q22 Atlas Genet Cytogenet Oncol Haematol. 2008;12(6) 455